Drug intelligence / Profile preview

fenticonazole

Development stage
Phase 3
Modality
Small Molecules
Administration
Topical, Vaginal
01

Overview

Fenticonazole is an imidazole antifungal drug primarily used topically as the nitrate salt for the treatment of vulvovaginal candidiasis and other superficial fungal infections. It exhibits a broad spectrum of activity against dermatophytes, yeasts (including Candida albicans), and some gram-positive bacteria such as Staphylococcus aureus. Fenticonazole also demonstrates antiparasitic action against Trichomonas vaginalis. Its mechanism of action involves inhibition of ergosterol synthesis—an essential component for fungal cell membrane integrity—by blocking fungal cytochrome P450-dependent enzymes that convert lanosterol to ergosterol. Additionally, it inhibits oxidizing enzymes (oxidases and peroxidases), leading to accumulation of toxic peroxides and necrosis in fungal cells. The drug also increases membrane permeability in bacteria and inhibits pyruvate oxido-reductase in protozoa, contributing to its antibacterial and antiprotozoal effects[1][3][6][7]. Fenticonazole is available in various topical formulations including creams, sprays, ovules, and vaginal capsules.

Brand names
LomexinGynoxinFentizol
Other names
fenticonazole nitrate
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on fenticonazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fenticonazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call